Prospective Study
Copyright ©The Author(s) 2017.
World J Hepatol. Mar 8, 2017; 9(7): 401-408
Published online Mar 8, 2017. doi: 10.4254/wjh.v9.i7.401
Table 1 Baseline characteristics and body composition of patients with cirrhosis
VariablePA > 4.9º (n = 73)PA ≤ 4.9º (n = 61)Total (n = 134)P valuea
Age (yr)52.10 ± 9.8056.90 ± 9.8054.30 ± 10.100.0051
Weight (kg)76.60 ± 13.1076.40 ± 15.3076.50 ± 14.100.9191
Height (m)1.70 ± 0.101.70 ± 0.101.70 ± 0.100.5361
Child Pugh A (%)251018
Child Pugh B (%)456555
Child Pugh C (%)3025270.0313
Model for end-stage liver disease score13.41 ± 5.1114.95 ± 4.6514.11 ± 4.950.0733
Severe ascites (%)10.0029.0018.200.0163
Encephalopathy (%)40.0060.0050.000.0443
Body mass index (kg/m2)26.70 ± 4.1026.40 ± 5.0026.60 ± 4.500.6831
Mid-arm muscle circumference (cm)25.80 ± 3.2023.20 ± 3.1024.70 ± 3.40< 0.0011
Handgrip strength (kg)31.80 ± 7.0024.40 ± 8.9028.60 ± 8.70< 0.0011
IL-6/IL-10 ratio (pg/mL)1.10 (0.51; 2.35)1.29 (0.71; 4.68)1.17 (0.58; 2.68)0.0862
C-reactive protein (mg/dL)0.88 (0.42; 1.96)1.20 (0.60; 4.72)1.09 (0.54; 2.62)0.0302
Albumin (g/dL)3.90 (3.40; 4.30)3.50 (2.90; 3.80)3.60 (3.20; 4.20)0.0022
Table 2 Mortality estimates for patients with cirrhosis from a multiple Cox regression model
VariableHR (95%CI)P value
Age (yr)1.03 (1.00, 1.06)0.042
MELD score1.10 (1.05, 1.16)0.001
Phase angle 50 kHz (< 4.9º)2.05 (1.11, 3.77)0.021